Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020		58,201,000
Beginning balance at Dec. 31, 2020	$ 421,232	$ 58	$ 702,768	$ (281,594)	$ 0
Increase (Decrease) in Stockholders' Equity [Rollforward]
Sale of common stock in a public offering, net of offering costs (in shares)		8,547,000
Sale of common stock in a public offering, net of offering costs of $38,677	593,821	$ 9	593,812
Issuance of common stock for acquisition (in shares)		3,347,000
Issuance of common stock for acquisition	147,089	$ 3	147,086
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)		947,000
Issuance of common stock on exercise of stock options and vesting of restricted stock units	9,175	$ 1	9,174
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)		81,000
Issuance of common stock under employee stock purchase plan (ESPP)	2,353		2,353
Tax portion of vested restricted stock units	(9,029)		(9,029)
Stock-based compensation expense (employee)	20,795		20,795
Stock-based compensation expense (non-employee)	61		61
Stock-based compensation expense (ESPP)	1,663		1,663
Net loss	(75,563)			(75,563)
Comprehensive income (loss)	(15,083)				(15,083)
Ending balance (in shares) at Dec. 31, 2021		71,123,000
Ending balance at Dec. 31, 2021	1,096,514	$ 71	1,468,683	(357,157)	(15,083)
Increase (Decrease) in Stockholders' Equity [Rollforward]
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)		681,000
Issuance of common stock on exercise of stock options and vesting of restricted stock units	4,194	$ 1	4,193
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)		155,000
Issuance of common stock under employee stock purchase plan (ESPP)	3,748		3,748
Tax portion of vested restricted stock units	(3,167)		(3,167)
Stock-based compensation expense (employee)	24,781		24,781
Stock-based compensation expense (non-employee)	11		11
Stock-based compensation expense (ESPP)	1,942		1,942
Net loss	(36,560)			(36,560)
Comprehensive income (loss)	$ (16,263)				(16,263)
Ending balance (in shares) at Dec. 31, 2022	71,959,454	71,959,000
Ending balance at Dec. 31, 2022	$ 1,075,200	$ 72	1,500,191	(393,717)	(31,346)
Increase (Decrease) in Stockholders' Equity [Rollforward]
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)		1,160,000
Issuance of common stock on exercise of stock options and vesting of restricted stock units	6,425	$ 1	6,424
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)		146,000
Issuance of common stock under employee stock purchase plan (ESPP)	3,153		3,153
Tax portion of vested restricted stock units	(6,741)		(6,741)
Stock-based compensation expense (employee)	31,494		31,494
Stock-based compensation expense (ESPP)	1,647		1,647
Net loss	(74,404)			(74,404)
Comprehensive income (loss)	$ 7,328				7,328
Ending balance (in shares) at Dec. 31, 2023	73,264,738	73,265,000
Ending balance at Dec. 31, 2023	$ 1,044,102	$ 73	$ 1,536,168	$ (468,121)	$ (24,018)